Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro

Chiang,I-Tsang; Wang,Wei-Shu; Liu,Hsin-Chung; Yang,Su-Tso; Tang,Nou-Ying; Chung,Jing-Gung

doi:10.3892/or.2015.4159

Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro

Authors:
- I-Tsang Chiang
- Wei-Shu Wang
- Hsin-Chung Liu
- Su-Tso Yang
- Nou-Ying Tang
- Jing-Gung Chung
View Affiliations

Affiliations: Department of Radiation Oncology, National Yang-Ming University Hospital, Yilan 260, Taiwan, R.O.C., Department of Internal Medicine, National Yang-Ming University Hospital, Yilan 260, Taiwan, R.O.C., Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan, R.O.C., Department of Radiology, China Medical University Hospital, Taichung 404, Taiwan, R.O.C., Graduate Institute of Chinese Medicine, China Medical University, Taichung 404, Taiwan, R.O.C.
Published online on: July 29, 2015 https://doi.org/10.3892/or.2015.4159
Pages: 1853-1874

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung cancer is the most common cause of cancer mortality and new cases are on the increase worldwide. However, the treatment of lung cancer remains unsatisfactory. Curcumin has been shown to induce cell death in many human cancer cells, including human lung cancer cells. However, the effects of curcumin on genetic mechanisms associated with these actions remain unclear. Curcumin (2 µM) was added to NCI-H460 human lung cancer cells and the cells were incubated for 24 h. Total RNA was extracted from isolated cells for cDNA synthesis, labeling, microarray hybridization and flour‑labeled cDNA hybridized on chip. Localized concentrations of fluorescent molecules were detected and quantified using Expression Console software (Affymetrix) with default RMA parameters. GeneGo software was used for the key genes involved and their possible interaction pathways. The results showed that ~170 genes were significantly upregulated and 577 genes were significantly downregulated in curcumin‑treated cells. Specifically, the up‑ and downregulated genes included CCNE2, associated with DNA damage; ID3, associated with cell survival and 146 genes with a >2- to 3-fold change including the TP53INP1 gene, associated with DNA damage; CDC6, CDCA5, TAKMIP2, CDK14, CDK5, CDCA76, CDC25A, CDC5L and SKP2, associated with cell cycle; the CARD6, ID1 and ID2 genes, associated with cell survival and the BRMS1L, associated with cell migration and invasion. Additionally, 59 downregulated genes exhibited a >4-fold change, including the DDIT3 gene, associated with DNA damage; while 97 genes had a >3- to 4-fold change including the DDIT4 gene, associated with DNA damage; the CCPG1 gene, associated with cell cycle and 321 genes with a >2- to 3-fold including the GADD45A and CGREF1 genes, associated with DNA damage; the CCPG1 gene, associated with cell cycle, the TNFRSF10B, GAS5, TSSC1 and TNFRSF11B gene, associated with cell survival and the ARHAP29 and CADM2 genes, associated with cell migration and invasion. In conclusion, gene alterations provide information regarding the cytotoxic mechanism of curcumin at the genetic level and provide additional biomarkers or targets for the treatment of human lung cancer.

View Figures

View References

1	Buyukcelik A, Yalcin B and Utkan G: Multidisciplinary management of lung cancer. N Engl J Med. 350:2008–2010. 2004. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, Gao J, Lieb W, Shieh K and Colford JM Jr: Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials. J Clin Oncol. 24:419–430. 2006. View Article : Google Scholar : PubMed/NCBI
4	Tsai MF, Wang CC and Chen JJ: Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer. World J Clin Oncol. 5:865–873. 2014. View Article : Google Scholar : PubMed/NCBI
5	Prasad S, Tyagi AK and Aggarwal BB: Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Res Treat. 46:2–18. 2014. View Article : Google Scholar : PubMed/NCBI
6	Hasima N and Aggarwal BB: Cancer-linked targets modulated by curcumin. Int J Biochem Mol Biol. 3:328–351. 2012.
7	Campbell FC and Collett GP: Chemopreventive properties of curcumin. Future Oncol. 1:405–414. 2005. View Article : Google Scholar
8	Sarkar FH and Li Y: Cell signaling pathways altered by natural chemopreventive agents. Mutat Res. 555:53–64. 2004. View Article : Google Scholar : PubMed/NCBI
9	Shishodia S, Sethi G and Aggarwal BB: Curcumin: Getting back to the roots. Ann NY Acad Sci. 1056:206–217. 2005. View Article : Google Scholar
10	Zanotto-Filho A, Braganhol E, Edelweiss MI, Behr GA, Zanin R, Schröder R, Simões-Pires A, Battastini AM and Moreira JC: The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J Nutr Biochem. 23:591–601. 2012. View Article : Google Scholar
11	Xiao K, Jiang J, Guan C, Dong C, Wang G, Bai L, Sun J, Hu C and Bai C: Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells. J Pharmacol Sci. 123:102–109. 2013. View Article : Google Scholar : PubMed/NCBI
12	Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ, Wu YQ, Song J, Yan J, Wu LJ and Lv GY: Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. J Nutr Biochem. 25:177–185. 2014. View Article : Google Scholar : PubMed/NCBI
13	Lev-Ari S, Starr A, Katzburg S, Berkovich L, Rimmon A, Ben-Yosef R, Vexler A, Ron I and Earon G: Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts. J Nutr Biochem. 25:843–850. 2014. View Article : Google Scholar : PubMed/NCBI
14	Shen Y, Zhang S, Huang X, Chen K, Shen J and Wang Z: Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cells. Biomed Res Int. 2014:9202752014. View Article : Google Scholar : PubMed/NCBI
15	Muller PA and Vousden KH: p53 mutations in cancer. Nat Cell Biol. 15:2–8. 2013. View Article : Google Scholar
16	Bunn PA Jr: Worldwide overview of the current status of lung cancer diagnosis and treatment. Arch Pathol Lab Med. 136:1478–1481. 2012. View Article : Google Scholar : PubMed/NCBI
17	Eberhard DA, Johnson BE, Amler LC, Goddard AD, Heldens SL, Herbst RS, Ince WL, Jänne PA, Januario T, Johnson DH, et al: Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non- small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol. 23:5900–5909. 2005. View Article : Google Scholar : PubMed/NCBI
18	Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, Ou SH, Dezube BJ, Jänne PA, Costa DB, et al: Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 363:1693–1703. 2010. View Article : Google Scholar : PubMed/NCBI
19	Wu SH, Hsiao YT, Chen JC, Lin JH, Hsu SC, Hsia TC, Yang ST, Hsu WH and Chung JG: Bufalin alters gene expressions associated DNA damage, cell cycle, and apoptosis in human lung cancer NCI-H460 cells in vitro. Molecules. 19:6047–6057. 2014. View Article : Google Scholar : PubMed/NCBI
20	Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, et al: Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics. 7:3252006. View Article : Google Scholar : PubMed/NCBI
21	Li Z, Meng Q, Yu Q, Zhou Z and Li L: Evaluation of c-myc and CCNE2 amplification in breast cancer with quantitative multigene fluorescence in-situ hybridization. Zhonghua Bing Li Xue Za Zhi. 43:455–458. 2014.In Chinese. PubMed/NCBI
22	Kawase T, Ichikawa H, Ohta T, Nozaki N, Tashiro F, Ohki R and Taya Y: p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis. Oncogene. 27:3797–3810. 2008. View Article : Google Scholar : PubMed/NCBI
23	Shahbazi J, Lock R and Liu T: Tumor protein 53-induced nuclear protein 1 enhances p53 function and represses tumorigenesis. Front Genet. 4:802013. View Article : Google Scholar : PubMed/NCBI
24	Kim GS, Kang J, Bang SW and Hwang DS: Cdc6 localizes to S- and G2-phase centrosomes in a cell cycle-dependent manner. Biochem Biophys Res Commun. 456:763–767. 2015. View Article : Google Scholar
25	Bidkhori G, Narimani Z, Hosseini Ashtiani S, Moeini A, Nowzari-Dalini A and Masoudi-Nejad A: Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma. PLoS One. 8:e675522013. View Article : Google Scholar : PubMed/NCBI
26	Davidson G and Niehrs C: Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol. 20:453–460. 2010. View Article : Google Scholar : PubMed/NCBI
27	Ding Y, Zhu W, Sun R, Yuan G, Zhang D, Fan Y and Sun J: Diphenylene iodonium interferes with cell cycle progression and induces apoptosis by modulating NAD(P)H oxidase/ROS/cell cycle regulatory pathways in Burkitt's lymphoma cells. Oncol Rep. 33:1434–1442. 2015.PubMed/NCBI
28	Jiang DS, Wei X, Zhang XF, Liu Y, Zhang Y, Chen K, Gao L, Zhou H, Zhu XH, Liu PP, et al: IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat Commun. 5:33032014. View Article : Google Scholar : PubMed/NCBI
29	Li L, Chen W, Zhu Y, Wang X, Jiang DS, Huang F, Wang L, Xiang F, Qin W, Wang Q, et al: Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload. Hypertension. 64:94–102. 2014. View Article : Google Scholar : PubMed/NCBI
30	Norton JD: ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci. 113:3897–3905. 2000.PubMed/NCBI
31	Lasorella A, Uo T and Iavarone A: Id proteins at the cross-road of development and cancer. Oncogene. 20:8326–8333. 2001. View Article : Google Scholar
32	Sikder HA, Devlin MK, Dunlap S, Ryu B and Alani RM: Id proteins in cell growth and tumorigenesis. Cancer Cell. 3:525–530. 2003. View Article : Google Scholar : PubMed/NCBI
33	Sun LY, Bokov AF, Richardson A and Miller RA: Hepatic response to oxidative injury in long-lived Ames dwarf mice. FASEB J. 25:398–408. 2011. View Article : Google Scholar :
34	Martins C, Doran C, Silva IC, Miranda C, Rueff J and Rodrigues AS: Myristicin from nutmeg induces apoptosis via the mitochondrial pathway and down regulates genes of the DNA damage response pathways in human leukaemia K562 cells. Chem Biol Interact. 218:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
35	Wang X, Liu Y, Shao D, Qian Z, Dong Z, Sun Y, Xing X, Cheng X, Du H, Hu Y, et al: Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer. Gastric Cancer. Jan 25–2015, (Epub ahead of print). http://dx.doi.org/10.1007/s10120-015-0467-2. View Article : Google Scholar
36	Kino T, Hurt DE, Ichijo T, Nader N and Chrousos GP: Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 3:ra82010. View Article : Google Scholar : PubMed/NCBI
37	Mourtada-Maarabouni M, Hasan AM, Farzaneh F and Williams GT: Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript s5 (GAS5). Mol Pharmacol. 78:19–28. 2010. View Article : Google Scholar : PubMed/NCBI